Danielle Pastor/cancer.gov
Jan 25, 2025, 05:06
Danielle Pastor Leads Clinical Trial on ANK-101 Immunotherapy – NCI Center for Cancer Research
NCI Center for Cancer Research shared a post on LinkedIn:
“Now Enrolling: Danielle Pastor, D.O., Ph.D., Assistant Research Physician in the CCR Center for Immuno-Oncology, is leading a clinical trial researching the safety and efficacy of the immunotherapy ANK-101.
Are you a physician with a patient you want to refer?
Contact the NCI Cancer Information Service for more information and provide the trial ID: NCT06171750.
More posts featuring NCI Center for Cancer Research.
-
Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Apr 4, 2025, 19:34
Apr 4, 2025, 19:19
Apr 4, 2025, 18:55
Apr 4, 2025, 18:06
Apr 4, 2025, 17:22
Apr 4, 2025, 15:01
Apr 4, 2025, 14:54